HomeOKUR • NASDAQ
add
Onkure Therapeutics Inc
Previous close
$2.94
Day range
$2.81 - $3.11
Year range
$1.70 - $9.40
Market cap
41.32M USD
Avg Volume
148.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.50M | 34.65% |
Net income | -14.70M | -27.20% |
Net profit margin | — | — |
Earnings per share | -1.09 | -26.74% |
EBITDA | -15.39M | -35.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 70.33M | 783.67% |
Total assets | 72.84M | 439.20% |
Total liabilities | 6.41M | -65.80% |
Total equity | 66.43M | — |
Shares outstanding | 13.55M | — |
Price to book | 0.60 | — |
Return on assets | -48.77% | — |
Return on capital | -53.05% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -14.70M | -27.20% |
Cash from operations | -13.04M | -22.29% |
Cash from investing | -6.00K | 66.67% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -13.04M | -22.19% |
Free cash flow | -7.91M | -24.22% |
About
Founded
2011
Headquarters
Website
Employees
46
